# EDGAR Filing Document

**Accession Number:** 0001660046
**File Stem:** 0001213900-26-070276
**Filing Date:** 2026-6
**Character Count:** 7204
**Document Hash:** ca951ae8cacd25b9f3629f51be7d031d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-070276.hdr.sgml**: 20260622

**ACCESSION NUMBER**: 0001213900-26-070276

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20260618

**FILED AS OF DATE**: 20260622

**DATE AS OF CHANGE**: 20260618

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Immuron Ltd
- **CENTRAL INDEX KEY:** 0001660046
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C3
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38104
- **FILM NUMBER:** 261104517

**BUSINESS ADDRESS:**
- **STREET 1:** 62 LYGON STREET
- **STREET 2:** LEVEL 3
- **CITY:** CARLTON, VICTORIA
- **STATE:** C3
- **ZIP:** 3053
- **BUSINESS PHONE:** 61 03 9824 5254

**MAIL ADDRESS:**
- **STREET 1:** 62 LYGON STREET
- **STREET 2:** LEVEL 3
- **CITY:** CARLTON, VICTORIA
- **STATE:** C3
- **ZIP:** 3053

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16 UNDER**

**THE SECURITIES EXCHANGE ACT OF 1934**

For the Month of June 2026

Commission File Number: 001-38104

**<u>IMMURON LIMITED</u>**

(Name of Registrant)

**<u>Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia</u>**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☒

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

**IMMURON LIMITED**

**<u>EXPLANATORY NOTE</u>**

Immuron Limited (the "Company") published an announcement (the "Public Notices") to the Australian Securities Exchange on June 18, 2026 titled:

- Appendix 3H – Notification of Cessation of Securities

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

**EXHIBITS**

---

| | |
|:---|:---|
| **Exhibit** <br> **Number** | **Description** |
| 99.1 | [Appendix 3H – Notification of Cessation of Securities](ea029524201ex99-1.htm) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **IMMURON LIMITED** | **IMMURON LIMITED** |
| Date: June 18, 2026 | By: | /s/ Olga Smejkalova |
|  |  | Olga Smejkalova |
|  |  | Company Secretary |

---

## Exhibit 99.1

**Exhibit 99.1**

---

| | |
|:---|:---|
| ![](ea029524201_ex99-1img1.jpg) | Appendix 3H - Notification of cessation of securities |

---

<u>Announcement Summary</u>

**Entity name**

IMMURON LIMITED

**Announcement Type**

New announcement

**Date of this announcement**

Thursday June 18, 2026

**Details of +securities that have ceased**

---

| | | | | |
|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**ASX +security code** | &nbsp;&nbsp;**Security<br> description** | &nbsp;&nbsp;**Number of<br> +securities<br> that have<br> ceased** | &nbsp;&nbsp;**The +securities have<br> ceased due to** | &nbsp;&nbsp;**Date of<br> cessation** |
| &nbsp;&nbsp;IMCAI | &nbsp;&nbsp;OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES | &nbsp;&nbsp;1430000 | &nbsp;&nbsp;Expiry of option or other convertible security without exercise or conversion | &nbsp;&nbsp;18/06/2026 |

---

Refer to next page for full details of the announcement

---

| | |
|:---|:---|
| ![](ea029524201_ex99-1img1.jpg) | Appendix 3H - Notification of cessation of securities |

---

<u>Part 1 - Announcement Details</u>

&nbsp;&nbsp;&nbsp;&nbsp;1.1 Name of +Entity

IMMURON LIMITED

We (the entity named above) provide the following information about our issued capital.

---

| | |
|:---|:---|
| **1.2 Registered Number Type** | **Registration Number** |
| ABN | 80063114045 |

---

&nbsp;&nbsp;&nbsp;&nbsp;1.3 ASX issuer code

IMC

&nbsp;&nbsp;&nbsp;&nbsp;1.4 The announcement is

New announcement

&nbsp;&nbsp;&nbsp;&nbsp;1.5 Date of this announcement

18/6/2026

---

| | |
|:---|:---|
| ![](ea029524201_ex99-1img1.jpg) | Appendix 3H - Notification of cessation of securities |

---

<u>Part 2 - Details of +equity securities or +debt securities that have ceased</u>

**ASX +Security Code and Description**

IMCAI : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

**Unquoted +equity securities that have ceased <br> Number of securities that have ceased <br> 1,430,000**

**Reason for cessation**

Expiry of option or other convertible security without exercise or conversion

---

| | |
|:---|:---|
| **Date of cessation** | **Is the entity paying any consideration for the cessation?** |
| 18/6/2026 | No |

---

**Any other information the entity wishes to notify to ASX about the cessation?**

---

| | |
|:---|:---|
| ![](ea029524201_ex99-1img1.jpg) | Appendix 3H - Notification of cessation of securities |

---

<u>Part 3 - Issued capital following changes</u>

**Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:**

The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

&nbsp;&nbsp;&nbsp;&nbsp;3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

---

| | |
|:---|:---|
| **ASX +security code and description** | **Total<br> number of <br> +securities<br> on issue** |
| IMC : ORDINARY FULLY PAID | 326653609 |

---

&nbsp;&nbsp;&nbsp;&nbsp;3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

---

| | |
|:---|:---|
| **ASX +security code and description** | **Total<br> number of <br> +securities<br> on issue** |
| IMCAE : PERFORMANCE RIGHTS | 3767492 |
| IMCAI : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES | 8000000 |

---

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.